How To Value a Dental Practice: A 7-Step Guide

Key Takeaways

• Doctor-to-doctor sales typically value practices at 65–85% of annual collections. DSO or private-equity buyers instead use normalized EBITDA multiples, which can yield substantially higher prices.

• Normalized EBITDA comes from a CPA-led, line-by-line adjustment of owner compensation, add-backs, and non-recurring items. This process creates a defensible earnings figure that can stand up to buyer diligence.

• Valuation multiples can be some of the main factors that scale with revenue size, EBITDA margin, and transferability. Crossing revenue tiers can add multiple turns, and specialty practices often command premium ranges.

• Key swing factors such as owner production dependency, hygiene recall, payer mix, facility condition, and staff stability can move a practice 10–20% within its multiple range.

• McLerran & Associates produces diligence-grade valuations and models net proceeds across deal structures so sellers see what they are likely to keep after debt, fees, and taxes.

Get A Diligence-Grade Valuation Before You Go To Market

Step 1: Match Your Valuation Method To Your Likely Buyer

Two methods dominate dental practice valuation, and the right one depends on who is buying. For doctor-to-doctor sales, the percentage-of-collections benchmark for how to value a dental practice based on collections remains the standard shorthand. For DSO and private-equity buyers, normalized EBITDA and the multiple applied to it is the governing metric.

Smaller premier practices, commonly in the $1–$1.5 million revenue range, tend to fit the doctor-to-doctor path. Larger practices with meaningful associate production and higher EBITDA attract institutional buyers willing to pay a significant premium. Practices in the $1.5–$3 million revenue middle can go either way. The difference in outcome between the two paths can be substantial. Private Practice Research’s 2026 valuation framework illustrates that a $2 million revenue practice with a 20% EBITDA margin could value at $1.3–$1.7 million to a private buyer versus $2.4–$2.8 million to a DSO buyer, a gap driven by buyer type and the earnings basis each uses.

Seller’s discretionary earnings (SDE) and EBITDA are not interchangeable metrics. SDE includes the owner’s full clinical compensation in the earnings figure, which produces a larger number and a lower multiple by convention. EBITDA, on the other hand, substitutes a market-rate associate salary for the owner’s pay, yielding a leaner figure and a higher multiple. As Spiro Leunes, CPA, CEO of MRL Advisory Group, explains, a practice quoted at 3× SDE and the same practice quoted at 6× EBITDA can represent the identical price. That difference in earnings base is why the same practice can appear to have two different values.

McLerran & Associates is a dental-only sell-side advisor that has evaluated more than 10,000 practices and completed roughly 2,000 successful sales. Every engagement begins with a CPA-led EBITDA analysis and a comprehensive valuation. This diligence-grade work happens before the practice goes to market so the number is more likely to hold when buyers scrutinize it. The firm represents sellers only and runs both transition paths in roughly equal measure, giving owners a genuine side-by-side comparison. For a deeper look at methodology, see Dental Practice Valuation Methods: Know Your Worth and How To Value A Dental Practice: Multiples & Methods.

Talk Through Which Valuation Method Fits Your Practice

Step 2: Use The Rule Of Thumb As A Screen, Not A Final Answer

Rules of thumb give a quick starting point, but they do not answer what a specific practice is worth. The three most common benchmarks in dental practice valuation are:

1. A percentage of annual gross collections, typically cited in the 65–85% range for general dentistry in private sales, per Private Practice Research’s 2026 Baseline Report.

2. A multiple of SDE for owner-operator sales to another dentist who will work in the practice.

3. A multiple of normalized EBITDA for institutional buyers such as DSOs and private-equity-backed groups.

A rule of thumb applied to gross collections ignores overhead entirely. Private Practice Research’s 2026 report makes this concrete. Two practices each collecting $1 million, one at 60% overhead and one at 75% overhead, would both value at $750,000 under a 75% collections multiplier despite earning very different profits. The collections method measures revenue, not profitability, so it functions as a screen rather than a final answer.

For a practical tool to begin estimating your range, see the Dental Practice Valuation Calculator: Owner’s Guide.

Step 3: Build A Normalized EBITDA Figure That Buyers Can Trust

Normalized EBITDA is the step that separates a defensible valuation from a back-of-the-napkin guess. Consider a hypothetical general dental practice collecting $1.8 million annually, with reported overhead above 70% and the owner taking a substantial total compensation package. The practice’s reported net income on its tax return is modest. That number tells a buyer very little on its own.

To see how a modest tax-return net income becomes a defensible EBITDA figure, walk through the same seven adjustments a buyer’s diligence team will apply:

1. Start with reported net income. Use the figure shown on the practice’s tax return.

2. Add back interest, taxes, depreciation, and amortization to reach raw EBITDA.

3. Normalize owner compensation. Replace the owner’s actual compensation with a market-rate associate salary for the clinical work performed, which might be approximately $280,000–$350,000, per Windsor Drake’s dental valuation analysis. Add back the excess of actual compensation over that market rate.

4. Add back documented personal and discretionary expenses run through the practice, such as personal vehicle, owner-directed continuing education, club memberships, and personal insurance, to the extent each is documented and supportable.

5. Add back one-time and non-recurring items such as a legal settlement or a one-time equipment repair.

6. Adjust for non-arm’s-length rent. If the owner also owns the building and charges below-market rent, record the below-market gap as a negative adjustment because the buyer will pay market rent post-close.

7. Arrive at normalized EBITDA. This is the figure that will carry the multiple.

Applied to a general range of multiples for a practice of this size, this normalized EBITDA produces a meaningfully different number than the collections rule of thumb would suggest. It also produces a very different number depending on buyer type. A private buyer might apply a lower multiple appropriate for a solo-doctor practice. A DSO buyer, if the practice qualifies, might apply a higher multiple reflecting institutional demand. The two ranges often do not overlap, and the difference can amount to hundreds of thousands of dollars.

One critical caveat comes from DentalReviewed’s 2026 valuation analysis, which reports that a typical quality-of-earnings scrub, the formal review a buyer’s team conducts during diligence, removes roughly 15–25% of an owner’s claimed add-backs. Every struck add-back is multiplied by the deal multiple, so an unsupported $50,000 add-back at a 6× multiple costs $300,000 in enterprise value. The normalization should be documented and defensible before the practice goes to market.

Step 4: Apply A Multiple That Reflects Size, Specialty, And Scale

Dental practice valuation multiples sit in ranges with rationale rather than fixed tables. The multiple can be some of the main factors that scale with revenue, EBITDA, doctor count, and expandability because larger practices often carry less owner dependency and more durable revenue. Smaller tuck-in practices sit at the lower end of the range, regional add-ons in the middle, and emerging or established platforms at the upper end.

Tier crossings can matter a great deal. Private Practice Research’s 2026 Baseline Report notes that crossing from the $1–$3 million adjusted EBITDA tier into the $3–$5 million tier can add approximately 2 turns of multiple. Scale is paid twice, once in larger EBITDA and again in a larger multiple applied to it.

Specialty can shift buyer demand and, in general terms, the multiple range. Oral and maxillofacial surgery commands the highest multiples and remains the fastest-consolidating dental segment, per McLerran & Associates. General dentistry still earns aggressive, near-all-time-high valuations. Specialties with heavier Medicaid exposure or narrower buyer pools tend to sit at the lower end of their respective ranges. These are general characterizations. The specific multiple for any practice is determined by its individual fundamentals, not a specialty label.

Step 5: Use Swing Factors To Move Toward The Top Of Your Range

Once the multiple range is established, several practice-specific factors can be some of the main factors that determine where within that range a practice lands.

Owner production dependency. When the owner generates 90% or more of clinical revenue, buyers see a practice that may not survive the owner’s exit intact. Buyers are pricing the risk that patients follow the departing doctor rather than staying with the practice.

Hygiene recall and retention. Strong hygiene revenue can signal patient retention and a healthier restorative pipeline. Buyers assess what share of eligible patients leave each hygiene visit with the next one booked, known as the reappointment rate. A practice with robust hygiene recall presents more predictable, recurring revenue than one where hygiene is understaffed or reappointment is inconsistent.

Payer mix. A Medicaid-heavy payer mix compresses margin and buyer appetite. Fee-for-service and in-network PPO revenue are viewed more favorably because they give the buyer more control over future fee schedules.

Facility and equipment condition. Deferred equipment creates post-close capital expenditure the buyer must fund. Private Practice Research’s 2026 report describes this as “Tech Debt,” the cost a buyer incurs to modernize an analog practice. Tech Debt can directly reduce sale price by narrowing the buyer pool and reducing competitive bidding.

Staff stability. Long-tenured clinical staff and a stable associate base reduce transition risk. An associate without a contractual retention mechanism can represent a significant discount to the EBITDA underwrite if the buyer prices in departure risk.

Step 6: Translate Enterprise Value Into Net Proceeds You Keep

The enterprise value, or headline number, rarely matches what the owner keeps. Converting a valuation to net proceeds requires working through several reductions.

First, subtract practice debt. Loans tied to the practice, equipment notes, and lines of credit are typically paid off at closing out of the seller’s proceeds. Obtain current payoff letters and model any prepayment penalties before signing.

Second, subtract advisory fees, legal fees, and closing costs. Third, account for taxes. In most dental practice asset sales, goodwill typically represents the largest share of value. That goodwill is taxed at long-term capital gains rates, which top out at 20% federally for most sellers. Higher earners may also owe the 3.8% Net Investment Income Tax, plus state income tax. Equipment allocated within the purchase price may be subject to depreciation recapture under Section 1245, taxed as ordinary income at rates up to 37%. Non-compete payments are also ordinary income. The allocation of the purchase price among these categories can swing the seller’s after-tax result by tens of thousands of dollars or more. This is education only. Consult your own CPA and attorney before agreeing to any allocation.

Fourth, and critically for DSO deals, the headline number often differs from the cash number. Precision Dental Analytics reports that prevailing DSO deal terms typically range from 40–60% cash at close, 15–20% escrow holdback, and 20–40% rollover equity. Rollover equity, a stake in the acquiring DSO platform, is illiquid and carries no guaranteed return. Its value is realized only when the platform itself achieves a liquidity event, typically within a 3–7 year hold period, per Windsor Drake. Equity can be held at the joint-venture level, tracking the seller’s own practice or regional group, or at the holding-company level, whose value depends on the entire platform’s performance. The economics of these two structures differ materially.

McLerran & Associates produces multi-year, multi-structure financial forecasting so owners can compare real after-tax cash across deal structures, such as private buyer versus DSO, cash versus equity, and earnout versus no earnout, before signing anything. For a candid look at what free valuations typically omit from this analysis, see Is A Free Dental Practice Valuation Worth It?

Model Your After-Tax Proceeds With McLerran & Associates

Step 7: Use A Pre-Sale Self-Audit To Catch Issues Early

The same items that feed the normalized EBITDA calculation in Step 3 become the self-audit checklist. Before any buyer or advisor sees the practice’s financials, the owner can gather and review:

• Three years of tax returns and profit-and-loss statements, consistently formatted with the same chart of accounts.

• Production and collections reports broken out by provider for the trailing 24–36 months.

• Owner compensation detail, including W-2, distributions, and any benefits or perks run through the practice.

• A written list of personal or discretionary expenses run through the business, with supporting documentation for each.

• One-time capital expenditures and any non-recurring items, with invoices or settlement papers.

• Hygiene recall rate and reappointment percentage.

• Payer mix breakdown, including fee-for-service, PPO, and any government program participation.

• Owner production percentage as a share of total practice production.

When Should You Stop Estimating And Get A Real Valuation?

A back-of-the-napkin number from a free-valuation lead-generation firm often becomes the anchor that quietly determines what the owner walks away with. That number is typically produced without a full normalization, without documented add-backs, and without the quality-of-earnings discipline that survives buyer scrutiny. Precision Dental Analytics reports that 85% of lower-middle-market deals see the price adjusted after the letter of intent. In those cases, the deal gets re-traded once the buyer’s team runs the real numbers.

McLerran & Associates takes a different approach. The firm builds a CPA-led, diligence-grade valuation before the practice goes to market so the number is more likely to hold when buyers look under the hood. With roughly 2,000 successful practice sales, approximately $2 billion in closed transaction volume, and roughly 35 years in business, the firm reports a transaction rate of approximately 85–90%, versus an industry norm closer to 35–40%. Clients tend to achieve roughly 30% higher valuations on average than owners achieve selling alone.

Owners who have not yet decided whether to sell may benefit from attending the McLerran M&A Summit, October 29–30, 2026, a dental-only event built for owners who want to get educated before committing to any path, with 4 CE credits and a complimentary practice valuation included.

Conclusion: Move From A Rough Range To A Defensible Number

How much a dental practice is worth often comes down to four elements: the right valuation method for the buyer type, a normalized EBITDA figure that survives diligence, a multiple set by practice size and transferability, and a net-proceeds calculation that accounts for debt, fees, taxes, and deal structure. A range found online cannot answer those questions for a specific practice.

McLerran & Associates is the dental-only sell-side advisor that produces the diligence-grade number up front, creates competition among vetted buyers so that number is more likely to hold, and models what the owner actually keeps across deal structures. The firm represents sellers only, in every engagement.

To start the conversation, call (512) 900-7989, email info@dentaltransitions.com, or use the link below.

Start Your Confidential Practice Sale Planning Call

Frequently Asked Questions

The questions below expand on the concepts covered in the steps above and address common points of confusion about SDE versus EBITDA, owner dependency, rollover equity, and timing.

What Is the Difference Between SDE and EBITDA in a Dental Practice Valuation, and Why Does It Matter?

Seller’s Discretionary Earnings (SDE) and EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) measure profitability differently. Confusing them is one of the most common valuation errors in dental practice sales.

As explained in Step 1, SDE and EBITDA differ in how they treat owner compensation, which changes both the earnings base and the multiple applied to it. SDE often fits doctor-to-doctor sales where the buyer will step into the chair. EBITDA often fits DSO and institutional deals where the buyer wants to see what the business earns after paying a market-rate associate.

The practical consequence is that a practice quoted at 3× SDE and the same practice quoted at 6× EBITDA can represent the identical price. Comparing offers without knowing which earnings base each uses can create confusion. McLerran & Associates builds both calculations for clients weighing both paths so the comparison is closer to apples to apples.

How Does Owner Production Dependency Affect What My Practice Is Worth?

Owner production dependency is one of the most significant and most controllable factors in dental practice valuation. When the selling doctor personally generates the large majority of clinical revenue, buyers price in the risk that patients follow the departing owner rather than staying with the practice. This risk can translate into a meaningful reduction in the multiple applied to normalized EBITDA, a longer required work-back period post-sale, or a larger share of the price tied to earnout rather than cash at close.

A buyer is purchasing a durable revenue stream, not a single producer. A practice where associates and hygienists generate a meaningful share of production presents a more transferable asset, one whose revenue is less likely to walk out the door on the day the owner retires.

McLerran & Associates evaluates owner dependency as part of every comprehensive valuation and advises clients on which improvements are worth pursuing before going to market.

What Is Rollover Equity in a DSO Deal, and How Should I Think About It?

In most DSO acquisitions, the seller does not receive the entire headline price in cash at closing. A portion, often ranging from roughly 20% to 40% of the deal value, is structured as rollover equity, a stake in the acquiring DSO platform or its private-equity parent. The cash portion typically covers the remainder, though escrow holdbacks and earnouts can further reduce the immediate cash received.

Rollover equity is not cash. It is an illiquid minority position in a private company whose books the seller cannot audit and whose exit timing the seller does not control. Its value is realized only when the platform achieves a liquidity event, such as a recapitalization, a sale to a larger sponsor, or an IPO, typically within a multi-year hold period. If the platform performs well and exits at a higher valuation than was applied to the seller’s practice, rolled equity can generate a meaningful “second bite.” If the platform underperforms or carries heavy debt, the rollover may return less than its stated value.

Equity can also be structured at different levels, such as the joint-venture level tracking the seller’s own practice or regional group, or the holding-company level tracking the entire platform. These two structures carry very different risk and return profiles. McLerran & Associates helps clients model the realistic after-tax, risk-adjusted value of each structure over multiple time horizons before any letter of intent is signed.

Why Does a Competitive Process Matter, and What Does McLerran & Associates Do Differently?

An unsolicited offer from a single DSO is a number set for the buyer’s benefit. A buyer negotiating with an unrepresented seller faces little competitive pressure to improve terms. The seller has limited ability to know whether the offer is at market, below market, or structured to shift risk onto the seller through earnouts and equity.

A structured, competitive process changes that dynamic. When multiple vetted buyers are simultaneously evaluating the same practice, each knows the others are present. That competition can push prices up and terms toward the seller. McLerran & Associates typically generates around 10 offers per listing through a 45–60 day bid process, then narrows to the top finalists for in-person meetings. The firm has blacklisted DSOs known for poor post-close environments, so only well-backed, well-run buyers reach the table.

That competitive process is why, as noted earlier, McLerran clients tend to achieve higher valuations than owners selling alone. The practice stays the same, but the process can reveal more of its true market value.

When Is the Right Time to Get a Formal Valuation?

The right time is often earlier than most owners expect. A formal, CPA-led valuation done two to three years before a target sale date serves several purposes. It establishes a defensible baseline, identifies the specific factors suppressing the multiple, and gives the owner time to address them before any buyer sees the numbers.

Those factors may include:

• Reducing owner dependency

• Cleaning up financials

• Improving hygiene recall

• Stabilizing the associate base

A valuation done after a buyer is already at the table, or after a letter of intent has been signed, gives the owner very limited leverage. The buyer’s quality-of-earnings team will run its own analysis, and any gap between the seller’s claimed EBITDA and the buyer’s accepted EBITDA is multiplied by the deal multiple. As noted in Step 3, an unsupported add-back can cost several times its face value in enterprise value.

McLerran & Associates builds the valuation before the practice goes to market, defends it through diligence, and updates it at no charge for clients who are not yet ready to transact. If a DSO has already approached you with an offer, that timing can also be appropriate for a call, before responding, before signing anything, and before the buyer’s anchor number becomes the starting point for negotiation.

What to Read Next

• Dental Practice Valuation Process: A Step-by-Step Guide

• How to Value Your Dental Practice for Sale: Seller’s Guide

• Dental Practice Valuation: Why the Numbers Differ

• Dental Practice Valuation Methods: Know Your Worth

• Dental Practice Valuation Calculator: Owner’s Guide